| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/23/2023 | 47.6% | Piper Sandler | $7 → $4 | Maintains | Neutral |
| 09/15/2023 | — | JP Morgan | Initiates Coverage On | → Underweight | |
| 08/09/2023 | 158.3% | Lake Street | $10 → $7 | Maintains | Buy |
| 08/09/2023 | 121.4% | Loop Capital | $9 → $6 | Downgrades | Buy → Hold |
| 08/09/2023 | 195.2% | Citigroup | $10 → $8 | Maintains | Buy |
| 08/09/2023 | 158.3% | Piper Sandler | $9 → $7 | Maintains | Neutral |
| 08/09/2023 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 06/12/2023 | 84.5% | Morgan Stanley | $9 → $5 | Downgrades | Equal-Weight → Underweight |
| 05/10/2023 | 269% | Citigroup | $12 → $10 | Maintains | Buy |
| 05/10/2023 | 342.8% | JMP Securities | $15 → $12 | Maintains | Outperform |
| 05/10/2023 | 213.65% | BMO Capital | $12 → $8.5 | Downgrades | Outperform → Market Perform |
| 05/10/2023 | 232.1% | Piper Sandler | $10 → $9 | Maintains | Neutral |
| 04/21/2023 | 342.8% | Citigroup | $13 → $12 | Maintains | Buy |
| 03/21/2023 | 453.51% | JMP Securities | → $15 | Reiterates | → Market Outperform |
| 02/24/2023 | 453.51% | JMP Securities | $20 → $15 | Maintains | Market Outperform |
| 02/24/2023 | 269% | Piper Sandler | $12 → $10 | Maintains | Neutral |
| 01/17/2023 | 232.1% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 11/11/2022 | 638.01% | JMP Securities | $26 → $20 | Maintains | Market Outperform |
| 11/11/2022 | 342.8% | Piper Sandler | $18 → $12 | Downgrades | Overweight → Neutral |
| 10/20/2022 | 564.21% | Piper Sandler | $26 → $18 | Maintains | Overweight |
| 09/01/2022 | 822.51% | Citigroup | → $25 | Initiates Coverage On | → Buy |
| 08/12/2022 | 859.41% | Piper Sandler | $25 → $26 | Maintains | Overweight |
| 08/11/2022 | — | Loop Capital | Upgrades | Hold → Buy | |
| 07/18/2022 | 822.51% | B of A Securities | $20 → $25 | Upgrades | Neutral → Buy |
| 06/15/2022 | 1007.01% | JP Morgan | $47 → $30 | Maintains | Overweight |
| 05/13/2022 | 674.91% | Citigroup | $27 → $21 | Maintains | Buy |
| 04/25/2022 | 822.51% | BMO Capital | → $25 | Initiates Coverage On | → Outperform |
| 03/31/2022 | 859.41% | JMP Securities | $44 → $26 | Maintains | Market Outperform |
| 03/31/2022 | 896.31% | Citigroup | $35 → $27 | Maintains | Buy |
| 03/31/2022 | 822.51% | Piper Sandler | $45 → $25 | Maintains | Overweight |
| 12/17/2021 | 1449.82% | B of A Securities | $45 → $42 | Maintains | Neutral |
| 12/06/2021 | 896.31% | JMP Securities | → $27 | Initiates Coverage On | → Market Outperform |
| 12/06/2021 | 1745.02% | Citigroup | → $50 | Initiates Coverage On | → Buy |
| 12/06/2021 | 1560.52% | B of A Securities | → $45 | Initiates Coverage On | → Neutral |
| 12/06/2021 | 1560.52% | Loop Capital | → $45 | Initiates Coverage On | → Buy |
| 12/06/2021 | 2003.32% | JP Morgan | → $57 | Initiates Coverage On | → Overweight |
| 12/06/2021 | 1560.52% | Piper Sandler | → $45 | Initiates Coverage On | → Overweight |
What is the target price for Expensify (EXFY)?
The latest price target for Expensify (NASDAQ: EXFY) was reported by Piper Sandler on October 23, 2023. The analyst firm set a price target for $4.00 expecting EXFY to rise to within 12 months (a possible 47.60% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Expensify (EXFY)?
The latest analyst rating for Expensify (NASDAQ: EXFY) was provided by Piper Sandler, and Expensify maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Expensify (EXFY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Expensify, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Expensify was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.
Is the Analyst Rating Expensify (EXFY) correct?
While ratings are subjective and will change, the latest Expensify (EXFY) rating was a maintained with a price target of $7.00 to $4.00. The current price Expensify (EXFY) is trading at is $2.71, which is out of the analyst's predicted range.